Fluicell AB (publ) (STO:FLUI)
Sweden · Delayed Price · Currency is SEK 26.40
-1.70 (-6.05%)
Oct 14, 2026, 4:29 PM CET
Fluicell AB Market Cap
Fluicell AB has a market cap or net worth of 36.27 million as of October 14, 2026. It is the 46,019th most valuable company in the world and the 706th biggest in Sweden. Its market cap has increased by 72.55% in one year.
Market Cap
36.27M
Enterprise Value
38.24M
Revenue
18.44M
Global Rank
Country Rank
#706 Sweden
PE Ratio
12.98
ChartMarket Cap Chart
Since April 18, 2018, Fluicell AB's market cap has decreased from 113.77M to 36.27M, a decrease of -68.12%. That is a compound annual growth rate of -12.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 36.27M | 164.00% |
| Dec 30, 2025 | 13.74M | -30.31% |
| Dec 30, 2024 | 19.71M | 14.60% |
| Dec 29, 2023 | 17.20M | -54.87% |
| Dec 30, 2022 | 38.12M | -85.77% |
| Dec 30, 2021 | 267.82M | 14.56% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Apr 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OncoZenge AB | 99.36M |
| Active Biotech AB | 92.26M |
| Ascelia Pharma AB | 90.80M |
| Biovica International AB | 86.70M |
| Spago Nanomedical AB | 83.43M |
| Nanologica AB | 81.86M |
| Pila Pharma AB | 75.60M |
| Annexin Pharmaceuticals AB | 73.93M |